BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 9.11 (2026-05-21)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BridgeBio Oncology Therapeutics, Inc (BBOT) Revenue data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
Revenue
--
$-42.11M
--
--
$46.18M
$-46.18M
$4.07M
$-42.11M
$-42.11M
$-42.11M
$-42.11M
$-42.11M
$-42.11M
$-46.18M
$-45.99M
80.03M
80.03M
$-526.11
$-526.11
Balance Sheet Financials
$266.50M
$0.94M
$151.14M
$417.65M
$43.26M
--
$2.11M
$45.37M
$372.28M
$372.28M
$372.28M
80.09M
Cash Flow Statement Financials
$-35.92M
$-285.41M
$0.29M
$373.82M
$52.79M
$-321.03M
$3.87M
--
--
Fundamental Metrics & Ratios
6.16
--
--
--
--
--
--
--
--
--
--
$-35.94M
--
--
--
--
--
--
--
-11.31%
-11.31%
-10.08%
-11.31%
$4.65
$-0.45
$-0.45